PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsstatus asthmaticus
MeSH D013224 - status asthmaticus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001249:Asthma
$
Success rate
D013224: 
Status asthmaticus
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyHydrocortisone Hydrocortisone  1982-01-01   
Abbott BiotherapeuticsHydrocortisone A-hydrocort  1982-01-01   
Able LaboratoriesHydrocortisone Hemsol-hc  1992-06-19   
AllerganHydrocortisone Aeroseb-hc  1982-01-01   
Hydrocortisone Penecort  1984-06-06   
Hydrocortisone Acetasol  1982-01-13   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone butyrate Hydrocortisone Butyrate  2017-12-08   
Hydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
AlpharmaHydrocortisone Hydrocortisone  1982-06-07   
AltanaHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Hydrocortisone Hydrocortisone  1982-01-01   
Amring PharmaceuticalsHydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  2005-10-31   
ANI PharmaceuticalsHydrocortisone Cortenema  1982-01-01   
Hydrocortisone probutate Pandel  1997-02-28   
APP PharmaceuticalsHydrocortisone Hydrocortisone  1984-06-08   
Astex PharmaceuticalsHydrocortisone butyrate Locoid  1983-01-07   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
100%
4/4
Phase 3
60%
6/10
Approved: 6Overall Success rate: 40%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use